CompletedPhase 4ketamine

Adding Ketamine to Levobupivacaine in Paravertebral Block in Thoracotomy

Sponsored by Tanta University

NCT ID
NCT06011746
Target Enrollment
60 participants
Start Date
2023-08-30
Est. Completion
2024-01-26

About This Study

To evaluate the role of adding ketamine to levobupivacaine in PVB on acute and chronic pain in thoracotomy

Conditions Studied

KetamineLevobupivacaineParavertebral BlockAcute PainChronic Pain

Interventions

  • •Ketamine + Levobupivacaine
  • •Levobupivacaine

Eligibility

Age:18 Years - 75 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* Age 18-75 years.
* Both sexes.
* ASA (American Society of Anesthesiology) physical status II-III.
* Scheduled for open thoracotomy.

Exclusion Criteria:

* Contraindications to or failed paravertebral block .
* Body mass index (BMI) \>35 kg/m2.
* The likelihood of postoperative mechanical ventilation.
* Patients with coagulopathy, poorly controlled diabetes mellitus, depression or other psychiatric disorders that required antidepressant drugs, alcohol, or recreational drug addiction.
* Hypersensitivity to ketamine or levobupivacaine.

Study Locations (1)

Tanta University
Tanta, El-Gharbia, Egypt

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source

Adding Ketamine to Levobupivacaine in Paravertebral Block in Thoracotomy | Huxley